Recent investigations have demonstrated the importance of MAPK, PI3K/Akt, JAK/STAT, NF-kB, TCR and TLR downstream signaling to allow survival in CTCL. The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.